Annette Langer-Gould

Dr. Annette Langer-Gould


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in The Permanente Journal
Verified
Journal Article
Closed access
CKCorinna Koebnick
Corinna Koebnick
ALAnnette Langer-Gould
Annette Langer-Gould
MGMichael K Gould
Michael K Gould
CCChun R Chao
Chun R Chao
RIRajan L Iyer
Rajan L Iyer
SJSteven J Jacobsen
Steven J Jacobsen
Data from the memberships of large, integrated health care systems can be valuable for clinical, epidemiologic, and health services research, but a potential selection bias may threaten the inference to the population of interest. We reviewed administrative records of members of Kaiser Permanente Southern California (KPSC) in 2000 and 2010, and we compared their sociodemographic characteristics with those of the underlying population in the coverage area on the basis of US Census Bureau data. We identified 3,328,579 KPSC members in 2000 and 3,357,959 KPSC members in 2010, representing approximately 16% of the population in the coverage area. The distribution of sex and age of KPSC members appeared to be similar to the census reference population in 2000 and 2010 except with a slightly higher proportion of 40 to 64 year olds. The proportion of Hispanics/Latinos was comparable between KPSC and the census reference population (37.5% vs 38.2%, respectively, in 2000 and 45.2% vs 43.3% in 2010). However, KPSC members included more blacks (14.9% vs 7.0% in 2000 and 10.8% vs 6.5% in 2010). Neighborhood educational levels and neighborhood household incomes were generally similar between KPSC members and the census reference population, but with a marginal underrepresentation of individuals with extremely low income and high education. The membership of KPSC reflects the socioeconomic diversity of the Southern California census population, suggesting that findings from this setting may provide valid inference for clinical, epidemiologic, and health services research.

7 May 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
ALAnnette Langer-Gould
Annette Langer-Gould
SBSonu M. Brara
Sonu M. Brara
BBBrandon E. Beaber
Brandon E. Beaber
JZJian L. Zhang
Jian L. Zhang
Objective: To determine whether the incidence of multiple sclerosis (MS) varies by race/ethnicity in a multiethnic, population-based cohort. Methods: We conducted a retrospective cohort study of more than 9 million person-years of observation from the multiethnic, community-dwelling members of Kaiser Permanente Southern California health plan from January 1, 2008 to December 31, 2010. Incidence of MS and risk ratios comparing incidence rates between racial/ethnic groups were calculated using Poisson regression. Results: We identified 496 patients newly diagnosed with MS who met McDonald criteria. The average age at diagnosis was 41.6 years (range 8.6–78.3 years) and 70.2% were women. The female preponderance was more pronounced among black (79.3%) than white, Hispanic, and Asian individuals with MS (67.8%, 68.1%, and 69.2%, respectively; p = 0.03). The incidence of MS was higher in blacks (10.2, 95% confidence interval [CI] 8.4–12.4; p < 0.0001) and lower in Hispanics (2.9, 95% CI 2.4–3.5; p < 0.0001) and Asians (1.4, 95% CI 0.7–2.4; p < 0.0001) than whites (6.9, 95% CI 6.1–7.8). Black women had a higher risk of MS (risk ratio 1.59, 95% CI 1.27–1.99; p = 0.0005) whereas black men had a similar risk of MS (risk ratio 1.04, 95% CI = 0.67–1.57) compared with whites. Conclusions: Our findings do not support the widely accepted assertion that blacks have a lower risk of MS than whites. A possible explanation for our findings is that people with darker skin tones have lower vitamin D levels and thereby an increased risk of MS, but this would not explain why Hispanics and Asians have a lower risk of MS than whites or why the higher risk of MS among blacks was found only among women.

5 February 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
ALAnnette Langer-Gould
Annette Langer-Gould
SBSonu M. Brara
Sonu M. Brara
BBBrandon E. Beaber
Brandon E. Beaber
CKCorinna Koebnick
Corinna Koebnick
Objective: To determine whether childhood obesity is a risk factor for developing pediatric multiple sclerosis (MS) or clinically isolated syndrome (CIS). Methods: Cases were identified through the Kaiser Permanente Southern California (KPSC) Pediatric Acquired Demyelinating Diseases Cohort between 2004 and 2010. For cases, body mass index (BMI) was obtained prior to symptom onset, for the underlying cohort BMI was obtained through the KPSC Children9s health study (n = 913,097). Weight classes of normal weight, overweight, moderate obesity, and extreme obesity were assigned based on BMI specific for age and sex. Results: We identified 75 newly diagnosed pediatric cases of MS or CIS, the majority of which were in girls (n = 41, 55%), age 11–18 (n = 54, 72%). Obesity was associated with a significantly increased risk of MS/CIS in girls (p = 0.005 for trend) but not in boys (p = 0.93). The adjusted odds ratio and 95% confidence intervals for CIS/MS among girls was 1.58 (0.71–3.50) for overweight compared to normal weight (reference category), 1.78 (0.70–4.49) for moderately obese, and 3.76 (1.54–9.16) for extremely obese. Moderately and extremely obese cases were more likely to present with transverse myelitis compared with normal/overweight children (p = 0.003). Conclusion: Our findings suggest the childhood obesity epidemic is likely to lead to increased morbidity from MS/CIS, particularly in adolescent girls.

20 September 2011 in Neurology
Verified
Journal Article
Closed access
PDF file
ALAnnette Langer-Gould
Annette Langer-Gould
JZJ.L. Zhang
J.L. Zhang
JCJ. Chung
J. Chung
YYY. Yeung
Y. Yeung
EWE. Waubant
E. Waubant
JYJ. Yao
J. Yao
Objective: To determine whether the incidence and clinical features of pediatric multiple sclerosis (MS) and other forms of pediatric acquired demyelinating syndromes (ADS) vary by race/ethnicity in a population-based cohort. Methods: We used a combination of electronic database searches followed by complete medical records review to identify all children diagnosed with MS and ADS in the multiethnic membership of Kaiser Permanente Southern California from January 1, 2004, to December 31, 2009. Incidence rates were standardized to the US census by age and gender. Results: We identified 81 incident cases of ADS from 4.87 million person-years of observation in children 0–18 years of age. The incidence rate of pediatric MS was 0.51 per 100,000 person-years (95% confidence interval [CI] 0.33–0.75) and incidence of other forms of ADS including optic neuritis, transverse myelitis, other forms of clinically isolated syndrome (CIS), and acute disseminated encephalomyelitis (ADEM) was 1.56 (95% CI 1.23–1.95) for an overall incidence of ADS of 1.66 per 100,000 person-years (95% CI 1.32–2.06). Incidence of ADS was higher in black (4.4 per 100,000 person-years, 95% CI 2.5–7.2, p < 0.001) and Asian/Pacific Islander (2.8, 95% CI 1.2–5.2, p = 0.02) than white (1.03, 95% CI 0.6–1.7) and Hispanic (1.5, 95% CI 1.1–2.1, per 100,000 person-years) children. Black children were also significantly more likely to have MS than white children (p = 0.001). Children who presented with ADEM were significantly younger than children with other types of ADS clinical presentations (mean age 5.6, range 0.7–17.6 years vs 14.6, range 2.7–18.5, respectively). Conclusions: The incidence of pediatric acquired demyelinating syndromes is 1.66 per 100,000 person-years in a population-based cohort of Southern Californian children. The incidence of ADS and MS is higher in black children compared with white and Hispanic children.

1 December 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
ALAnnette Langer-Gould
Annette Langer-Gould
LQLei Qian
Lei Qian
STSara Y. Tartof
Sara Y. Tartof
SBSonu M. Brara
Sonu M. Brara
SJSteve J. Jacobsen
Steve J. Jacobsen
HTHung Fu Tseng
Hung Fu Tseng
The concern that vaccinations could induce a small increased risk of multiple sclerosis (MS) and other acquired central nervous system demyelinating syndromes (CNS ADS) remains controversial.

12 May 2010 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
ALAnnette Langer-Gould
Annette Langer-Gould
KAKb Albers
Kb Albers
SESk Van Den Eeden
Sk Van Den Eeden
LNLm Nelson
Lm Nelson
The objective of this study was to determine whether patients with multiple sclerosis (MS) are more likely to have other autoimmune disorders particularly prior to the diagnosis of MS. We conducted a population-based case—control study of patients enrolled in the Northern California Kaiser Permanente Medical Care Program. Electronic clinical records through 2005 were used to ascertain incident and prevalent MS cases and identify the presence and timing of 44 other diagnoses. Controls were matched 5:1 for gender, age, and Kaiser membership characteristics. We identified 5296 MS cases (including 924 diagnosed between 2001 and 2004) and 26,478 matched controls. Prior to MS diagnosis, cases were more likely than controls to have uveitis (OR = 3.2, 95%; CI 1.7—5.7), inflammatory bowel disease (IBD, OR = 1.7; 95%CI 1.2—2.5), and Bell’s palsy (OR = 3.2; 95%CI 1.2—8.3). Cases were also more likely to develop Guillain— Barré syndrome (GBS, OR = 5.0; 95%CI 1.6—15.4) and bullous pemphigoid (OR = 6.7; 95%CI 1.5—29.9). Cases were not more likely than controls to have or to develop rheumatoid arthritis, lupus or thyroiditis. MS may share environmental triggers, genetic susceptibilities and/or alterations in immune homeostasis with IBD and uveitis, but not with other autoimmune disorders.